ANI Pharmaceuticals
ANIP
#5296
Rank
โ‚น145.64 B
Marketcap
โ‚น6,408
Share price
-3.27%
Change (1 day)
-9.86%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): โ‚น484.97

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น480.13. In 2025 the company made an earnings per share (EPS) of โ‚น324.42 an increase over its 2024 EPS that were of -โ‚น103.81.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น484.9749.49%
2025โ‚น324.42-412.5%
2024-โ‚น103.81
2022-โ‚น281.78-6.46%
2021-โ‚น301.2472.87%
2020-โ‚น174.26-476%
2019โ‚น46.35-62.12%
2018โ‚น122.35
2015โ‚น124.20-47.66%
2014โ‚น237.29-142.11%
2013-โ‚น563.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น486.62 1.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น65.81-86.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
โ‚น719.27 49.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น336.46-29.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-โ‚น233.58-148.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น403.20-183.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น41.71-91.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
โ‚น141.74-70.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-โ‚น2,343-588.03%๐Ÿ‡บ๐Ÿ‡ธ USA